Cargando…

HMGB1 enhances chemotherapy resistance in multiple myeloma cells by activating the nuclear factor-κB pathway

Chemotherapy resistance is a main obstacle in the clinical chemotherapeutic treatment of multiple myeloma (MM). High-mobility group box 1 (HMGB1) has been revealed to be associated with the sensitivity of MM cells to chemotherapy, but how HMGB1 regulates chemotherapy resistance in MM has yet to be f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Jing, Yang, Rui, Wang, Hainan, Cui, Lijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120504/ https://www.ncbi.nlm.nih.gov/pubmed/34007314 http://dx.doi.org/10.3892/etm.2021.10137

Ejemplares similares

Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma
por: Roy, Mridul, et al.
Publicado: (2016)

The NF-κB Activating Pathways in Multiple Myeloma
por: Roy, Payel, et al.
Publicado: (2018)

Hsa_Circ_0007841 Enhances Multiple Myeloma Chemotherapy Resistance Through Upregulating ABCG2
por: Song, Yan, et al.
Publicado: (2020)

ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF‐κB in multiple myeloma
por: Jiang, Jifeng, et al.
Publicado: (2020)

Activation of Serum/Glucocorticoid Regulated Kinase 1/Nuclear Factor-κB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells
por: Tsubaki, Masanobu, et al.
Publicado: (2021)

Drug Inhibition Profile Prediction for NFκB Pathway in Multiple Myeloma
por: Peng, Huiming, et al.
Publicado: (2011)

Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma
por: Zhu, Xuewei, et al.
Publicado: (2020)

Research on the Mechanism of HMGB1 Regulating Autoimmune Encephalomyelitis by Regulating NF-κB
por: Liu, Lijuan, et al.
Publicado: (2022)

PPFIBP1 activates NF-κB signaling to enhance chemoresistance of multiple myeloma
por: Deng, Yi, et al.
Publicado: (2023)

Knockdown of long non-coding RNA H19 inhibits multiple myeloma cell growth via NF-κB pathway
por: Sun, Yuanyuan, et al.
Publicado: (2017)

Targeting NF-κB Signaling for Multiple Myeloma
por: Wong, Ada Hang-Heng, et al.
Publicado: (2020)

Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
por: Zhou, Yifan, et al.
Publicado: (2020)

Repetitive transcranial magnetic stimulation for chemotherapy-induced peripheral neuropathy in multiple myeloma: A pilot study
por: Yan, Zhenzhuang, et al.
Publicado: (2023)

Resveratrol affects the migration and apoptosis of monocytes by blocking HMGB1/NF-κB pathway
por: Zhang, Yuwei, et al.
Publicado: (2021)

Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Burley, Thomas A., et al.
Publicado: (2022)

Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021)

Chrysophanol alleviates myocardial injury in diabetic db/db mice by regulating the SIRT1/HMGB1/NF-κB signaling pathway
por: Xue, Peng, et al.
Publicado: (2019)

Nuclear Fructose‐1,6‐Bisphosphate Inhibits Tumor Growth and Sensitizes Chemotherapy by Targeting HMGB1
por: Li, Yeyi, et al.
Publicado: (2023)

Nuclear Hmgb1: The Fix for the Failing Heart
por: Raucci, Angela, et al.
Publicado: (2019)

The short-term effect of histone deacetylase inhibitors, chidamide and valproic acid, on the NF-κB pathway in multiple myeloma cells
por: Liu, Zhaoyun, et al.
Publicado: (2019)

Evodiamine protects against airway remodelling and inflammation in asthmatic rats by modulating the HMGB1/NF-κB/TLR-4 signalling pathway
por: Wang, Qiong, et al.
Publicado: (2021)

VAD chemotherapy as remission induction for multiple myeloma.
por: Anderson, H., et al.
Publicado: (1995)

Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma
por: Johnstone, Megan, et al.
Publicado: (2022)

Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
por: Markovina, Stephanie, et al.
Publicado: (2010)

Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance
por: Li, Xin, et al.
Publicado: (2023)

Berberine Ameliorates Subarachnoid Hemorrhage Injury via Induction of Sirtuin 1 and Inhibiting HMGB1/Nf-κB Pathway
por: Zhang, Xiang-Hua, et al.
Publicado: (2020)

Activation of the HMGB1-TLR4-NF-κB pathway may occur in patients with atopic eczema
por: Wang, Yong, et al.
Publicado: (2017)

Study on Tim3 Regulation of Multiple Myeloma Cell Proliferation via NF-κB Signal Pathways
por: Liu, Zhaoyun, et al.
Publicado: (2020)

PTEN nuclear translocation enhances neuronal injury after hypoxia-ischemia via modulation of the nuclear factor-κB signaling pathway
por: Zhao, Jing, et al.
Publicado: (2021)

Immunoglobulin Free Light Chains and GAGs Mediate Multiple Myeloma Extracellular Vesicles Uptake and Secondary NfκB Nuclear Translocation
por: Di Noto, Giuseppe, et al.
Publicado: (2014)

Silencing of SENP2 in Multiple Myeloma Induces Bortezomib Resistance by Activating NF-κB Through the Modulation of IκBα Sumoylation
por: Xie, Hongyi, et al.
Publicado: (2020)

Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathways
por: Muraoka, Hiromi, et al.
Publicado: (2019)

XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma
por: Turner, Joel G., et al.
Publicado: (2016)

Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma
por: Han, Xiaoyan, et al.
Publicado: (2017)

The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma
por: Wang, Lei, et al.
Publicado: (2019)

Lycorine attenuates lipopolysaccharide-induced acute lung injury through the HMGB1/TLRs/NF-κB pathway
por: Ge, Xin, et al.
Publicado: (2020)

Inhibition of HMGB1 suppresses inflammation and catabolism in temporomandibular joint osteoarthritis via NF-κB signaling pathway
por: Li, Yan Yan, et al.
Publicado: (2022)

Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways
por: Zou, Chongchong, et al.
Publicado: (2022)

The STAT1/HMGB1/NF-κB pathway in chronic inflammation and kidney injury after cisplatin exposure
por: Fu, Ying, et al.
Publicado: (2023)

The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma
por: Tu, Yong-sheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_of6p5e50h41edimsk7m5fk25cn